Biolase, Inc. (BIOL) Social Stream

Biolase, Inc. (BIOL): $4.75

-0.24 (-4.81%)

POWR Rating

Component Grades













Biolase Inc (BIOL) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering BIOL.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2022-03-18 1 $2 $2 $2 $0.355 463.38%
2022-03-22 1 $2.001 $2 $2 $0.355 463.38%

Price Target Last Issued March 22, 2022

The Trend in the Analyst Price Target

BIOL's average price target has moved up $0.59 over the prior 14 months.

Over the past 50 weeks, BIOL's average upside potential has been 219.74%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-04-10 1 2 1.75 1.94 1.010 92.08%
2021-05-22 1 2 2.00 2.00 0.737 171.37%
2021-07-10 1 2 2.00 2.00 0.659 203.49%
2021-07-24 1 2 2.00 2.00 0.589 239.56%
2021-08-13 1 2 2.00 2.00 0.790 153.16%

BIOL Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
2 0 1 0 0 0 1

The Trend in the Broker Recommendations

BIOL's average broker recommendation rating worsened by 0.25 over the prior 151 days.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for BIOL as an investment opportunity.

  • BIOL has a greater number of analysts covering the stock than practically none of all US stocks.
  • Biolase Inc's average analyst price target is greater than 0.84% of all US stocks.
  • BIOL has a lower variance in analysts' estimates than 94.15% of Healthcare stocks.
  • In terms of how Biolase Inc fares relative to Medical Equipment stocks, note that its upside potential (average analyst target price relative to current price) is higher than 189.62% of that group.

In the Medical Equipment industry, RXST, CHEK, and POAI are the three stocks most similar to Biolase Inc regarding the price target and analyst recommendation information presented here.

Is BIOL a Buy, Hold or Sell? See the POWR Ratings now!

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.478 seconds.